studies on retatrutide Phase III study demonstrates 30% weight loss Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Weekly dosage schedule Starting dose: 0.25 mg weekly for first 4 weeks Titration phase: 0.5 mg weekly for 4 weeks and then, if tolerated, 1 mg weekly for 4 weeks Maintenance dose for long-term weight management: 1.7 mg once weekly for 4 weeks and then, if tolerated, 2.4 mg once weekly (maximum dose) Dosing considerations If you do not tolerate dose escalation, consult with your healthcare provider and consider delaying the dose escalation for at least 4 weeks

They help quiet constant food thoughts (food noise), reduce hunger between meals, and increase the sense of fullness after eating

Retrieved 6 May 2023

However, this effect has not been reported in humans

Verma S, McGuire DK, Bain SC, Bhatt DL, Leiter LA, Mazer CD, et al

There are different reasons people stop taking GLP-1s